Bill Chi Tran, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-San Jose. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-San JoseSan Jose, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-San Jose
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.22 to 2.37) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.43 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 271 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,952 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.04 to 0.5) · 894 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.19 (0.67 to 5.72) · 176 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 61 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.92) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.11 (0 to 17.58) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.53) · 630 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 48 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.843 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.88 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.611 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 171 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 571 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 147.1 · 28 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21 · 639 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 157 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,294 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$3,294
Medicare paid this office $3,294 for 98 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $563 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 66 | $534 | $7 |
Who their Medicare patients are
98 Original Medicare patients in 2024. Average age 72 · Under 65 15% · 85 and older 19% · Women 54% · Also on Medicaid 57% · Health risk score 2.44. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 40% · Heart failure 33% · Atrial fibrillation 32% · Coronary heart disease 30% · Stroke 24% · Cancer 19% · COPD 18% · Depression 17% · Dementia 17%.
The office billed $17,497, Medicare allowed $4,938 and paid $3,294; for 122 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 98 | 122 | 72 | 2.44 | $17,497 | $3,294 |
| 2023 | 134 | 222 | 70 | 2.21 | $24,070 | $5,052 |
| 2022 | 720 | 1,101 | 76 | 1.81 | $214,378 | $50,553 |
| 2021 | 1,008 | 1,538 | 75 | 1.76 | $313,116 | $76,689 |
| 2020 | 1,433 | 2,102 | 74 | 1.88 | $345,643 | $87,102 |
| 2019 | 1,273 | 2,259 | 75 | 1.87 | $428,360 | $115,651 |
| 2018 | 726 | 1,285 | 74 | 1.86 | $229,390 | $63,777 |
| 2017 | 625 | 1,086 | 74 | 1.89 | $191,903 | $54,182 |
| 2016 | 302 | 497 | 73 | 1.47 | $80,645 | $22,532 |
| 2015 | 33 | 52 | 74 | 2.26 | $11,759 | $2,962 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,161 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 105 | $958 | $7 |
2022: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $10,369 | $53 |
| Return visit (30+ min) | 85 | $6,947 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $4,690 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,421 | $104 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 56 | $3,398 | $61 |
| New patient visit (45+ min) | 29 | $3,086 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $2,956 | $141 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,195 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 65 | $1,087 | $17 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,017 | $85 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 18 | $917 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 79 | $649 | $7 |
| Ultrasound of heart, follow-up | 28 | $593 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 49 | $543 | $11 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $353 | $14 |
| Injection of x-ray contrast during ultrasound of heart | 14 | $353 | $25 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $347 | $18 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $296 | $21 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 47 | $268 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 49 | $123 | $2 |
2021: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 324 | $16,701 | $51 |
| Return visit (30+ min) | 140 | $14,704 | $92 |
| New patient visit (45+ min) | 57 | $7,069 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $5,662 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $4,820 | $142 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 76 | $4,388 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $2,953 | $102 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 106 | $1,711 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,447 | $80 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,204 | $86 |
| Short return visit (20+ min) | 14 | $944 | $67 |
| Ultrasound of heart, follow-up | 40 | $823 | $20 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $744 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 104 | $719 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 62 | $685 | $11 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 35 | $644 | $18 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 26 | $559 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $374 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 48 | $274 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 53 | $134 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $72 | $6 |
2020: 23 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 335 | $19,091 | $56 |
| Return visit (30+ min) | 120 | $9,793 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,817 | $159 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 98 | $5,974 | $61 |
| New patient visit (45+ min) | 47 | $5,791 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $5,683 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $4,842 | $82 |
| New patient visit (60+ min) | 26 | $4,268 | $164 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,243 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 358 | $2,890 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 122 | $2,204 | $18 |
| Long return visit (40+ min) | 15 | $1,517 | $101 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 83 | $1,275 | $15 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,023 | $85 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 41 | $842 | $21 |
| Ultrasound of heart, follow-up | 36 | $763 | $20 |
| Return visit (30+ min) | 13 | $739 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 65 | $714 | $11 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $691 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 90 | $552 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $389 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 45 | $264 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 54 | $145 | $3 |
2019: 29 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 295 | $16,708 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 121 | $14,749 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $13,850 | $159 |
| Return visit (30+ min) | 128 | $12,643 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 66 | $7,305 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,061 | $82 |
| Return visit (30+ min) | 56 | $3,979 | $60 |
| New patient visit (60+ min) | 22 | $3,527 | $160 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 47 | $2,956 | $63 |
| Ultrasound of heart with probe in esophagus, with report | 33 | $2,815 | $85 |
| Critical care, first 30-74 minutes | 11 | $2,781 | $174 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 15 | $2,755 | $184 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 102 | $2,143 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 116 | $2,016 | $17 |
| Hospital discharge day management, more than 30 minutes | 25 | $1,973 | $79 |
| New patient visit (45+ min) | 18 | $1,820 | $101 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 232 | $1,730 | $7 |
| New patient visit (45+ min) | 13 | $1,688 | $130 |
| Long return visit (40+ min) | 12 | $1,504 | $116 |
| Short return visit (20+ min) | 17 | $828 | $49 |
| Ultrasound of heart, follow-up | 35 | $744 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 61 | $699 | $11 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 11 | $552 | $50 |
| 3d radiographic procedure with computerized image postprocessing | 14 | $443 | $32 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $433 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 67 | $404 | $6 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $281 | $22 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 49 | $279 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | $160 | $2 |
2018: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $13,120 | $55 |
| Return visit (30+ min) | 101 | $9,688 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $7,019 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $7,008 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,050 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,808 | $106 |
| New patient visit (45+ min) | 32 | $3,642 | $114 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $1,685 | $56 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,512 | $84 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,296 | $86 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 160 | $1,175 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 50 | $803 | $16 |
| Short return visit (20+ min) | 16 | $744 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $698 | $29 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 31 | $577 | $19 |
| Ultrasound of heart, follow-up | 17 | $345 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $276 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 35 | $205 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $190 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $94 | $2 |
2017: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $8,409 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 168 | $7,751 | $46 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,649 | $155 |
| New patient visit (45+ min) | 49 | $6,046 | $123 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,535 | $105 |
| Return visit (30+ min) | 44 | $4,058 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $1,938 | $81 |
| Hospital discharge day management, more than 30 minutes | 23 | $1,927 | $84 |
| Short return visit (20+ min) | 27 | $1,771 | $55 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $1,492 | $62 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,292 | $81 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 130 | $1,023 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 57 | $931 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 22 | $443 | $20 |
| Ultrasound of heart, follow-up | 17 | $365 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $269 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 43 | $268 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 26 | $161 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $105 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $71 | $2 |
2016: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,056 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 61 | $2,922 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,801 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,203 | $100 |
| New patient visit (45+ min) | 15 | $1,907 | $127 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $1,385 | $58 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,080 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 42 | $730 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | $586 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $229 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $182 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 20 | $128 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $69 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $33 | $3 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,186 | $56 |
Medicaid work
$8,486 in 2024
Medicaid paid $8,486 for 603 billed services this clinician did in 2024, up to 89 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 586 | $5,748 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 17 | $2,738 |
| 2024 | 603 | 2 | 89 | $8,486 |
| 2023 | 794 | 3 | 93 | $2,146 |
| 2022 | 361 | 3 | 106 | $1,948 |
| 2021 | 39 | 1 | 14 | $2,068 |
| 2020 | 27 | 1 | 27 | $150 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 739 | $1,399 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 24 | $731 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 31 | $16 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 38 | $1,264 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 309 | $684 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 14 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 39 | $2,068 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 27 | $150 |
Drugs they prescribed that Part D paid
$592,304
Pharmacies billed $592,304 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,495) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,211 generic and 284 brand-name prescriptions · $592,304 in drug cost · 23 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 12 | $292,310 | $24,359 |
| Entresto | 101 | $159,367 | $1,578 |
| Eliquis | 27 | $45,686 | $1,692 |
| Jardiance | 57 | $29,830 | $523 |
| Pradaxa | 69 | $20,276 | $294 |
See all 28 drugs
| Vyndamax | 12 | $292,310 | $24,359 |
| Entresto | 101 | $159,367 | $1,578 |
| Eliquis | 27 | $45,686 | $1,692 |
| Jardiance | 57 | $29,830 | $523 |
| Pradaxa | 69 | $20,276 | $294 |
| Atorvastatin | 147 | $1,820 | $12 |
| Metoprolol | 119 | $1,527 | $13 |
| Sotalol | 53 | $1,376 | $26 |
| Losartan | 74 | $1,003 | $14 |
| Amiodarone | 32 | $993 | $31 |
| Carvedilol | 82 | $966 | $12 |
| Furosemide | 72 | $958 | $13 |
| Flecainide Acetate | 25 | $841 | $34 |
| Metoprolol | 70 | $836 | $12 |
| Clopidogrel | 43 | $807 | $19 |
| Potassium Chloride | 26 | $805 | $31 |
| Amlodipine Besylate | 58 | $756 | $13 |
| Nitroglycerin | 50 | $649 | $13 |
| Diltiazem 24hr Er (Cd) | 18 | $619 | $34 |
| Spironolactone | 57 | $539 | $9 |
| Isosorbide Mononitrate Er | 32 | $458 | $14 |
| Bumetanide | 13 | $421 | $32 |
| Hydralazine | 23 | $295 | $13 |
| Lisinopril | 23 | $288 | $13 |
| Rosuvastatin | 22 | $253 | $12 |
| Losartan-Hydrochlorothiazide | 15 | $195 | $13 |
| Atenolol | 11 | $128 | $12 |
| Amoxicillin | 15 | $88 | $6 |
Year by year
| 2024 | 1,495 | 329 | 0% (0) | 19% | $592,304 |
| 2023 | 1,385 | 415 | 0% (0) | 18% | $287,413 |
| 2022 | 2,843 | 437 | 0% (0) | 11% | $297,315 |
| 2021 | 2,809 | 420 | 0% (0) | None | $255,345 |
| 2020 | 2,885 | 385 | 0% (0) | 10% | $201,857 |
| 2019 | 2,544 | 375 | 0% (0) | 13% | $176,927 |
| 2018 | 1,741 | 274 | 0% (0) | 18% | $133,700 |
| 2017 | 816 | 173 | 0% (0) | 19% | $50,608 |
| 2016 | 96 | 35 | 0% (0) | 20% | $7,718 |
| 2015 | 79 | 17 | None | None | $9,963 |
| 2014 | 134 | 27 | 0% (0) | 22% | $4,917 |
| 2013 | 37 | None | 0% (0) | None | $3,342 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Entresto | 67 | $86,343 | $1,289 |
| Eliquis | 53 | $71,113 | $1,342 |
| Xarelto | 20 | $19,120 | $956 |
| Jardiance | 27 | $18,941 | $702 |
| Pradaxa | 32 | $9,610 | $300 |
| Metoprolol | 139 | $2,756 | $20 |
| Potassium Chloride | 30 | $2,487 | $83 |
| Amiodarone | 53 | $2,311 | $44 |
| Atorvastatin | 114 | $2,040 | $18 |
| Carvedilol | 97 | $1,390 | $14 |
| Bumetanide | 16 | $1,362 | $85 |
| Losartan | 69 | $1,075 | $16 |
| Furosemide | 92 | $1,015 | $11 |
| Flecainide Acetate | 27 | $984 | $36 |
| Clopidogrel | 38 | $825 | $22 |
| Diltiazem 24hr Er (Cd) | 22 | $801 | $36 |
| Isosorbide Mononitrate Er | 34 | $763 | $22 |
| Spironolactone | 49 | $740 | $15 |
| Lisinopril | 48 | $720 | $15 |
| Metoprolol | 68 | $714 | $10 |
| Amlodipine Besylate | 42 | $707 | $17 |
| Prasugrel | 13 | $589 | $45 |
| Nitroglycerin | 34 | $512 | $15 |
| Sotalol | 21 | $484 | $23 |
| Hydralazine | 19 | $391 | $21 |
| Rosuvastatin | 18 | $247 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $216 | $18 |
2022: 32 drugs
| Eliquis | 118 | $123,763 | $1,049 |
| Xarelto | 68 | $60,688 | $892 |
| Entresto | 24 | $23,516 | $980 |
| Repatha Sureclick | 18 | $20,275 | $1,126 |
| Potassium Chloride | 129 | $8,104 | $63 |
| Metoprolol | 333 | $7,473 | $22 |
| Atorvastatin | 273 | $4,852 | $18 |
| Losartan | 187 | $3,429 | $18 |
| Clopidogrel | 141 | $3,015 | $21 |
| Carvedilol | 225 | $2,910 | $13 |
| Torsemide | 73 | $2,160 | $30 |
| Rosuvastatin | 52 | $2,108 | $41 |
| Lisinopril | 188 | $1,835 | $10 |
| Spironolactone | 102 | $1,555 | $15 |
| Flecainide Acetate | 18 | $1,360 | $76 |
| Ezetimibe | 15 | $1,331 | $89 |
| Amiodarone | 27 | $1,310 | $49 |
| Furosemide | 195 | $1,286 | $7 |
| Diltiazem 24hr Er (Cd) | 36 | $1,191 | $33 |
| Isosorbide Mononitrate Er | 57 | $1,046 | $18 |
| Warfarin | 52 | $893 | $17 |
| Amlodipine Besylate | 60 | $764 | $13 |
| Nitroglycerin | 38 | $576 | $15 |
| Losartan-Hydrochlorothiazide | 14 | $458 | $33 |
| Famotidine | 36 | $445 | $12 |
| Metoprolol | 61 | $419 | $7 |
| Hydralazine | 21 | $385 | $18 |
| Simvastatin | 34 | $303 | $9 |
| Pantoprazole | 14 | $233 | $17 |
| Pravastatin | 12 | $164 | $14 |
| Jantoven | 11 | $135 | $12 |
| Benazepril | 25 | $129 | $5 |
2021: 34 drugs
| Eliquis | 91 | $102,679 | $1,128 |
| Xarelto | 65 | $52,717 | $811 |
| Entresto | 20 | $19,048 | $952 |
| Potassium Chloride | 153 | $8,183 | $53 |
| Metoprolol | 309 | $7,531 | $24 |
| Pradaxa | 12 | $6,042 | $504 |
| Atorvastatin | 279 | $5,098 | $18 |
| Carvedilol | 225 | $2,897 | $13 |
| Torsemide | 107 | $2,516 | $24 |
| Losartan | 122 | $2,463 | $20 |
| Rosuvastatin | 45 | $2,122 | $47 |
| Prasugrel | 11 | $1,932 | $176 |
| Lisinopril | 199 | $1,903 | $10 |
| Isosorbide Dinitrate | 13 | $1,857 | $143 |
| Clopidogrel | 137 | $1,820 | $13 |
| Furosemide | 269 | $1,780 | $7 |
| Bumetanide | 11 | $1,755 | $160 |
| Klor-Con M20 | 12 | $1,252 | $104 |
| Flecainide Acetate | 23 | $1,241 | $54 |
| Isosorbide Mononitrate Er | 89 | $1,179 | $13 |
| Spironolactone | 103 | $1,177 | $11 |
| Diltiazem 24hr Er (Cd) | 23 | $837 | $36 |
| Nifedipine Er | 14 | $723 | $52 |
| Metoprolol | 71 | $646 | $9 |
| Nitroglycerin | 40 | $564 | $14 |
| Warfarin | 43 | $527 | $12 |
| Famotidine | 24 | $506 | $21 |
| Amlodipine Besylate | 27 | $449 | $17 |
| Amiodarone | 15 | $424 | $28 |
| Losartan-Hydrochlorothiazide | 17 | $408 | $24 |
| Hydralazine | 17 | $316 | $19 |
| Simvastatin | 27 | $265 | $10 |
| Pravastatin | 12 | $153 | $13 |
| Benazepril | 20 | $146 | $7 |
2020: 37 drugs
| Eliquis | 69 | $68,940 | $999 |
| Xarelto | 50 | $37,747 | $755 |
| Entresto | 13 | $13,247 | $1,019 |
| Potassium Chloride | 204 | $9,192 | $45 |
| Brilinta | 11 | $8,163 | $742 |
| Metoprolol | 277 | $7,435 | $27 |
| Pradaxa | 12 | $5,811 | $484 |
| Atorvastatin | 265 | $4,466 | $17 |
| Torsemide | 144 | $4,117 | $29 |
| Sildenafil Citrate | 12 | $2,858 | $238 |
| Flecainide Acetate | 26 | $2,374 | $91 |
| Prasugrel | 13 | $2,350 | $181 |
| Bumetanide | 12 | $2,239 | $187 |
| Carvedilol | 207 | $1,965 | $9 |
| Rosuvastatin | 44 | $1,948 | $44 |
| Clopidogrel | 172 | $1,788 | $10 |
| Losartan | 109 | $1,724 | $16 |
| Isosorbide Mononitrate Er | 108 | $1,490 | $14 |
| Lisinopril | 207 | $1,357 | $7 |
| Furosemide | 242 | $1,331 | $5 |
| Warfarin | 73 | $1,077 | $15 |
| Spironolactone | 122 | $992 | $8 |
| Ezetimibe | 13 | $842 | $65 |
| Diltiazem 24hr Er (Cd) | 26 | $814 | $31 |
| Nitroglycerin | 51 | $730 | $14 |
| Pravastatin | 18 | $564 | $31 |
| Metoprolol | 56 | $517 | $9 |
| Metolazone | 12 | $484 | $40 |
| Famotidine | 34 | $471 | $14 |
| Hydralazine | 19 | $394 | $21 |
| Amlodipine Besylate | 35 | $275 | $8 |
| Jantoven | 13 | $194 | $15 |
| Losartan-Hydrochlorothiazide | 13 | $172 | $13 |
| Pantoprazole | 20 | $172 | $9 |
| Simvastatin | 20 | $164 | $8 |
| Hydrochlorothiazide | 18 | $68 | $4 |
| Atenolol | 11 | $42 | $4 |
2019: 37 drugs
| Eliquis | 90 | $54,048 | $601 |
| Xarelto | 58 | $39,613 | $683 |
| Brilinta | 26 | $12,432 | $478 |
| Pradaxa | 13 | $6,679 | $514 |
| Metoprolol | 198 | $6,551 | $33 |
| Potassium Chloride | 145 | $6,163 | $43 |
| Sildenafil Citrate | 30 | $5,004 | $167 |
| Rosuvastatin | 48 | $3,295 | $69 |
| Atorvastatin | 178 | $3,206 | $18 |
| Torsemide | 118 | $3,037 | $26 |
| Bumetanide | 17 | $2,866 | $169 |
| Enoxaparin | 12 | $2,103 | $175 |
| Flecainide Acetate | 27 | $2,067 | $77 |
| Carvedilol | 159 | $1,630 | $10 |
| Clopidogrel | 142 | $1,629 | $11 |
| Isosorbide Mononitrate Er | 98 | $1,536 | $16 |
| Warfarin | 88 | $1,305 | $15 |
| Metolazone | 32 | $1,263 | $39 |
| Furosemide | 195 | $1,091 | $6 |
| Klor-Con M20 | 14 | $1,017 | $73 |
| Lisinopril | 171 | $985 | $6 |
| Losartan | 92 | $843 | $9 |
| Spironolactone | 71 | $760 | $11 |
| Cartia Xt | 18 | $736 | $41 |
| Hydralazine | 36 | $730 | $20 |
| Pravastatin | 25 | $706 | $28 |
| Amiodarone | 34 | $620 | $18 |
| Nitroglycerin | 39 | $585 | $15 |
| Diltiazem 24hr Er (Cd) | 20 | $564 | $28 |
| Famotidine | 35 | $447 | $13 |
| Metoprolol | 58 | $411 | $7 |
| Amlodipine Besylate | 34 | $361 | $11 |
| Ezetimibe | 12 | $310 | $26 |
| Pantoprazole | 28 | $304 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $114 | $9 |
| Bisoprolol | 14 | $86 | $6 |
| Hydrochlorothiazide | 16 | $61 | $4 |
2018: 29 drugs
| Eliquis | 90 | $46,702 | $519 |
| Xarelto | 59 | $38,094 | $646 |
| Metoprolol | 157 | $6,249 | $40 |
| Potassium Chloride | 92 | $4,059 | $44 |
| Bumetanide | 14 | $2,671 | $191 |
| Torsemide | 64 | $2,114 | $33 |
| Atorvastatin | 111 | $1,954 | $18 |
| Rosuvastatin | 22 | $1,500 | $68 |
| Warfarin | 82 | $1,447 | $18 |
| Isosorbide Mononitrate Er | 68 | $1,150 | $17 |
| Flecainide Acetate | 14 | $1,140 | $81 |
| Clopidogrel | 97 | $1,138 | $12 |
| Carvedilol | 144 | $1,095 | $8 |
| Lisinopril | 132 | $942 | $7 |
| Cartia Xt | 27 | $891 | $33 |
| Furosemide | 137 | $787 | $6 |
| Klor-Con M20 | 16 | $696 | $43 |
| Losartan | 63 | $485 | $8 |
| Metoprolol | 63 | $438 | $7 |
| Nifedipine Er | 16 | $425 | $27 |
| Hydralazine | 13 | $376 | $29 |
| Pravastatin | 16 | $375 | $23 |
| Pantoprazole | 23 | $287 | $12 |
| Spironolactone | 23 | $278 | $12 |
| Amiodarone | 16 | $256 | $16 |
| Nitroglycerin | 15 | $248 | $17 |
| Amlodipine Besylate | 15 | $196 | $13 |
| Famotidine | 18 | $132 | $7 |
| Hydrochlorothiazide | 19 | $86 | $5 |
2017: 21 drugs
| Eliquis | 20 | $11,891 | $595 |
| Xarelto | 14 | $10,849 | $775 |
| Potassium Chloride | 36 | $3,547 | $99 |
| Metoprolol | 84 | $3,123 | $37 |
| Rosuvastatin | 21 | $1,666 | $79 |
| Atorvastatin | 46 | $865 | $19 |
| Bumetanide | 11 | $836 | $76 |
| Isosorbide Mononitrate Er | 30 | $786 | $26 |
| Torsemide | 30 | $729 | $24 |
| Warfarin | 34 | $697 | $21 |
| Furosemide | 96 | $648 | $7 |
| Clopidogrel | 40 | $563 | $14 |
| Lisinopril | 51 | $394 | $8 |
| Carvedilol | 52 | $348 | $7 |
| Nitroglycerin | 18 | $297 | $17 |
| Pantoprazole | 16 | $217 | $14 |
| Metoprolol | 21 | $213 | $10 |
| Amlodipine Besylate | 16 | $181 | $11 |
| Losartan | 25 | $181 | $7 |
| Amiodarone | 12 | $152 | $13 |
| Famotidine | 15 | $150 | $10 |
2016: 1 drug
| Furosemide | 12 | $112 | $9 |
2014: 2 drugs
| Clopidogrel | 26 | $575 | $22 |
| Lisinopril | 12 | $78 | $7 |
Money from drug and device companies
$42 in 2025
| 2025 | 1 | 1 | None | $42 |
| 2022 | 3 | 5 | None | $181 |
| 2021 | 1 | 5 | None | $177 |
| 2019 | 3 | 8 | None | $525 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotronik | Amvia Edge | $42 | 1 payment
|
See the published payment
| Biotronik | Meals · 2025-11-07 | Amvia Edge | $42 |
See earlier years (2022, 2021, 2019)
2022: $181
| Boston Scientific | General - Therapies | $88 | 1 payment
|
| Abiomed | Impella | $67 | 3 payments
|
| HeartFlow | Ffrct | $25 | 1 payment
|
2021: $177
| Abbott Laboratories | Mitraclip System | $177 | 5 payments
|
2019: $525
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $489 | 6 payments
|
| Abiomed | Impella | $20 | 1 payment
|
| Boston Scientific | Vigilant | $16 | 1 payment
|
Professional record
- NPI
- 1598908873
- Licence
- MN 56441
- Trained
- University of Rochester School of Medicine and Dentistry, 2009
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 270 International Cir, San Jose, CA, 95119
- NPI first listed
- 2009-04-15
- NPI last updated
- 2022-09-15
- NPI record certified
- 2022-09-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1200 Sixth Ave N, St Cloud, MN, 56303
This office lists an electronic records connection.